Therapy of diabetic polyneuropathy - present and future perspectives

Up to now, treatment of diabetic polyneuropathy remains unsatisfactory. Nev ertheless, new pathogenetic concepts about the possible reasons for the dev elopment of diabetic neuropathy create new therapeutic approaches to the di sease. The following article reviews the therapeutic agents commonly used. Furthermore some new substances are reported which interfere in the pathoge netic pathway of diabetic neuropathy and might be beneficial for the patien ts suffering from this neuropathy in the future.